US Drug Recall Register

FDA Drug Recalls

2,277 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Nystatin 500 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-3 D-0155-2024
Class II · Moderate risk Ongoing

Nystatin 5bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-5 D-0154-2024
Class II · Moderate risk Ongoing

Naproxen Tablets

Reason Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Glenmark Pharmaceuticals Inc., USA NDC 68462-188-01 D-0124-2024
Class II · Moderate risk Ongoing

Indomethacin 25mg Capsules

Reason Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Glenmark Pharmaceuticals Inc., USA NDC 68462-406-01 D-0123-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0122-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0121-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0120-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0119-2024
Class II · Moderate risk Ongoing

Ranolazine Extended-Release Tablets 500mg

Reason Failed Dissolution Specifications: Out of specification for dissolution.

Glenmark Pharmaceuticals Inc., USA NDC 68462-319-60 D-0092-2024
Class II · Moderate risk Ongoing

Equate Hand Sanitizer

Reason Sub Potent and Super Potent Product: During an impact assessment of the DOP Hand Sanitizer product, it was identified that several lots distributed did not comply with the finished good acceptance criteria established.

Omega & Delta Co., Inc. D-0105-2024
Class II · Moderate risk Ongoing

DOP Instant Hand Sanitizer

Reason Sub Potent and Super Potent Product: During an impact assessment of the DOP Hand Sanitizer product, it was identified that several lots distributed did not comply with the finished good acceptance criteria established.

Omega & Delta Co., Inc. D-0104-2024
Class II · Moderate risk Ongoing

DOP Instant Hand Sanitizer

Reason Sub Potent and Super Potent Product: During an impact assessment of the DOP Hand Sanitizer product, it was identified that several lots distributed did not comply with the finished good acceptance criteria established.

Omega & Delta Co., Inc. D-0103-2024
Class II · Moderate risk Ongoing

Certain Over-The-Counter

Reason CGMP Deviations: OTC products were stored outside of labeled temperature requirements.

Dollar Tree Distribution, Inc. D-0045-2024
Class II · Moderate risk Ongoing

Gynazole-1

Reason Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.

Padagis US LLC D-0081-2024
Class II · Moderate risk Ongoing

Triamcinolone Acetonide Injectable Suspension

Reason Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.

Eugia US LLC NDC 55150-385-01 D-0041-2024
Class II · Moderate risk Ongoing

octiq Lubricating Eye Drops

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1167-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1166-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1165-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1164-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1163-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1162-2023